AAT is a substantial socio-economic burden to livestock farmers in Sub-Saharan Africa, affecting and killing millions of cattle every year
Grant funding from the Bill & Melinda Gates Foundation will support the rapid and efficient design and synthesis of novel small molecules
This development will position the company at the forefront of anti- malaria API production globally and is expected to drive substantial growth and profitability
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
lAIH strives to introduce appropriate interventions for nurturing an AMR innovation ecosystem in the country through cohesive efforts across the innovation pyramid
Two biopharmaceutical experts join SK bioscience to strengthen the future strategies
35 million mosquito nets supplied to countries in sub-Saharan Africa through partners
The TBDA is a collaboration established among biopharmaceutical companies, research organizations and universities to accelerate the discovery and development of novel therapeutic candidates against TB.
Phase 2 study evaluating an investigational weekly oral combination treatment regimen of islatravir and Gilead Sciences’ lenacapavir to resume with lower dose of islatravir
Celanese to conduct research, prototype development and characterization of a refillable contraceptive technology with award from the Bill & Melinda Gates Foundation
Subscribe To Our Newsletter & Stay Updated
